Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Bridging Generations: Educating Children on Dementia and Fall Prevention Through Animation
Authors not listed
Northumbria University · 2021
Abstract
A retrospective data review was conducted on a case-control trial involving 60 children (29 boys, 31 girls) as part of a public education initiative hosted on the web-based platform "Hand in Hand Across Barriers - Public Education Platform" (Facebook).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Anonymous. (2021). Bridging Generations: Educating Children on Dementia and Fall Prevention Through Animation. <em>Northumbria University</em>. https://clinicaltrials.gov/study/NCT07000370
Vancouver
Anonymous. Bridging Generations: Educating Children on Dementia and Fall Prevention Through Animation. Northumbria University. 2021.
BibTeX
@misc{anon2021Bridgi,
title = {Bridging Generations: Educating Children on Dementia and Fall Prevention Through Animation},
author = {Anonymous},
journal = {Northumbria University},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Animal Behaviour 1991
Preprint · OA
Stereotypies: a critical review
F1000Research 2016
Open access · CC-BY
Peer Review Report For: Dietary restriction with and without caloric restriction for healthy aging [version 1; peer review: 3 approved]
Aging 2017
Open access · OA
The fat regulator neuropeptide Y and caloric restriction
F1000Research 2025
Open access · CC-BY
Peer Review Report For: Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders [version 2; peer review: 1 approved, 2 approved with reservations]
F1000Research 2025
Open access · CC-BY
Peer Review Report For: Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders [version 2; peer review: 1 approved, 2 approved with reservations]
Scientific Data 2026
Open access · CC-BY